Aldeyra Therapeutics Inc (ALDX)
SG&A Expense Growth
-100.00%
Quarterly · Period ending:
ALDX SG&A Expense Growth
Latest reported-100.00%period ending
Latest reported-100.00%period ending
ALDX Quarterly SG&A Growth (QoQ) (0.00% → -100.00%)
Latest values, visible window
High-resolution chart · PNG
ALDX sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| -99.9998% | |
| 48,103,998.5274% | |
| -8.0159% | |
| 54.5158% | |
| -44.6262% | |
| 54.236% | |
| -47.302% | |
| 21.6586% | |
| -5.3668% | |
| 78.4031% | |
| -30.4865% | |
| -23.4055% | |
| -39.2941% | |
| 17.5721% | |
| 45.9295% | |
| 3.2012% | |
| -26.0063% | |
| 65.8075% | |
| 0.6297% | |
| -17.0057% | |
| -1.1611% | |
| 23.9405% | |
| 11.0558% | |
| 1.6042% | |
| -26.1191% | |
| -6.5057% | |
| 13.1937% | |
| -8.8915% | |
| 4.4012% | |
| 17.2442% | |
| -16.9578% | |
| 29.1966% | |
| 25.4722% | |
| 25.9822% | |
| 1.717% | |
| -0.3974% | |
| -14.1924% | |
| 43.2113% | |
| -13.6682% | |
| -4.479% | |
| 0.4581% | |
| 18.6726% | |
| -2.7484% | |
| 32.0791% | |
| -1.7716% | |
| -3.4996% | |
| 30.4074% | |
| -21.3837% | |
| 22.7233% | |
| -3.8107% | |
| 66.3346% | |
| -24.2528% | |
| 367.5277% | |
| 597.6647% | |
| 0% |